Gravitate Health FHIR Implementation Guide
0.1.0 - CI Build

Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health/ and changes regularly. See the Directory of published versions

Example Bundle: ePI document Bundle for acmedrug-man Package Leaflet for language en

Composition category: Raw
Composition status: final

B. Package Leaflet

unavailable

Package leaflet: Information for the user

unavailable

What is in this leaflet

unavailable

1. What acme is and what it is used for

unavailable

2. What you need to know before you take acme

unavailable

3. How to take acme

unavailable

4. Possible side effects

unavailable

5. How to store acme

unavailable

6. Contents of the pack and other information

unavailable

acmedrug-man

IDS: ididid

Full name: acmedrug-man

- Invented name part: acme

- Scientific name part: acmedrug

- Strength part: 75 mg

- Pharmaceutical dose form part: tablet

Name usage: English (Denmark)

Authorised dose form:

Legal status of supply: Medicinal product subject to medical prescription

Domain: Human use

Resource status: active

Product classification:

Marketing Authorisation 1 of 1

Authorisation number: EU/1/96/007/035

Region:

Marketing authorisation holder: ACME industry

Identifier:

  • ORG-100000789

Status: Active (2015-02-07T13:28:17Z)

Package 1 of 2

PMSWI: dd

Description:

Marketing status:

Pack size:

  • 75

Package: 1 Box (Cardboard)

Containing:

Package: 28 Blister (PolyVinyl Chloride)

Containing:

Manufactured Item

Dose form: Aerosol

Unit of presentation: Bead

Ingredient

Role: Excipient

Substance: acmedrug-ing3

Ingredient

Role: Excipient

Substance: acmedrug-ing2

Ingredient

Role: Active

Substance: acmedrug-ing1

Package 2 of 2

PMSWI: dd

Description:

Marketing status:

Pack size:

  • 75

Package: 1 Box (Cardboard)

Containing:

Package: 96 Blister (PolyVinyl Chloride)

Containing:

Manufactured Item

Dose form: Aerosol

Unit of presentation: Bead

Ingredient

Role: Excipient

Substance: acmedrug-ing3

Ingredient

Role: Excipient

Substance: acmedrug-ing2

Ingredient

Role: Active

Substance: acmedrug-ing1

Administrable Product (1 of 1)

Dose form: Tablet

Unit of presentation: Tablet

Route of administration:

  • Oral use

Ingredients:

Ingredient

Role: Excipient

Substance: acmedrug-ing3

Ingredient

Role: Excipient

Substance: acmedrug-ing2

Ingredient

Role: Active

Substance: acmedrug-ing1